News

Ideas That Generate Results

The ability of Biosimilars to act as growth engines by ensuring broader access to medicines and sustainability is helping biosimilars gain value in emerging economies. Countries such as India, China, Korea, Vietnam and Brazil are witnessing remarkable biosimilar uptake as compared to advanced economies. This surge can be attributed to local policies or the fragmented regulatory framework and “biosimilar” attitude of emerging nations. South Korea in particular, with plans to become a leading biosimilars player, is actively expanding its world-class clinical trials and production infrastructure, cultivating bio-specialized manpower, reinforcing global export capability, and building R&D, legal and system support strategies.
 
As per the estimations of our latest report, “Global EPO Biosimilars Market Outlook 2018”, the global biosimilars market backed by the rise of bioclusters in emerging countries will grow at a CAGR of around 50% during 2012-2018. The report contains a thorough study of the EPO biosimilars market, and its future outlook. A basic overview of the total biologics market has been provided, alongwith its current and future size and the trends and drivers which would be responsible for shaping up the market. Some of these factors including rising collaborations among major pharma players and the strong government support to encourage the growth of biosimilars. This is then followed by the total biosimilar market and its future size. The major key segments of the market and their respective shares have also been highlighted.
 
A brief introduction of the global EPO biosimilar market, its estimated size and its future value has been given. We have also provided a list of the marketed EPO biosimilars and those that are in the pipeline. At the end, key players of the EPO biosimilar market have been profiled where focus has been rested on the business overview, key products and pipeline of the company. Overall, the report aims at providing reliable and complete information about the EPO biosimilar market to clients and potential investors.
 
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM656.htm
 
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm